SYMPLICITY HTN-3 | Clinical Trial - SYMPLICITY HTN-3

Description:

Renal denervation has shown promising results for the treatment of resistant hypertension in phase I and II trials. The current phase III trial sought to evaluate the safety and efficacy of renal artery denervation in patients with severe resistant hypertension.